sunitinib "teva" 25 mg kapsler, hårde
teva b.v. - sunitinib - kapsler, hårde - 25 mg
sunitinib "teva" 37,5 mg kapsler, hårde
teva b.v. - sunitinib - kapsler, hårde - 37,5 mg
sunitinib "teva" 50 mg kapsler, hårde
teva b.v. - sunitinib - kapsler, hårde - 50 mg
gefitinib mylan
mylan pharmaceuticals limited - gefitinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - gefitinib mylan er angivet som monoterapi til behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke‑småcellet lungekræft (nsclc) med aktiverende mutationer af egfr‑tk.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib "sandoz" 12,5 mg kapsler, hårde
sandoz a/s - sunitinib - kapsler, hårde - 12,5 mg
sunitinib "zentiva" 12,5 mg kapsler, hårde
zentiva k.s. - sunitinib - kapsler, hårde - 12,5 mg
sunitinib "teva" 12,5 mg kapsler, hårde
teva b.v. - sunitinib - kapsler, hårde - 12,5 mg
sunitinib "krka" 12,5 mg kapsler, hårde
krka d.d. novo mesto - sunitinibmalat - kapsler, hårde - 12,5 mg
gefitinib "stada" 250 mg filmovertrukne tabletter
stada arzneimittel ag - gefitinib - filmovertrukne tabletter - 250 mg